Nichols Garrett

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
5
Insider Sells Sum
$213,953.77

Insider Activity of Nichols Garrett

According to the SEC Form 4 filings, Nichols Garrett, being in a position of

  1. Chief Medical Officer at Candel Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 20644 shares for $128,744,
    over all time since 2024-07-11, has bought 0 shares, and sold 20644 shares for $128,744.

The largest sale of all time was on 2024-07-17 and amounted to 10875 shares of Candel Therapeutics, Inc. for $70,390.

Biography of Nichols Garrett

No biography is available at this moment.

2024-07-17SaleCandel Therapeutics, Inc.
CADL
Chief Medical Officer
10,875
0.036%
$6.47$70,390-4.26%
2024-07-11SaleCandel Therapeutics, Inc.
CADL
Chief Medical Officer
9,769
0.0343%
$5.97$58,3540%
2020-02-10SaleChimerix, Inc.
CMRX
Chief Medical Officer
8,805
0.0141%
$1.68$14,830+77.65%
2020-02-07SaleChimerix, Inc.
CMRX
Chief Medical Officer
2,550
0.0042%
$1.70$4,335+78.7%
2020-01-07SaleChimerix, Inc.
CMRX
Chief Medical Officer
30,680
0.0482%
$2.15$66,045+28.83%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.